BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Creabilis Therapeutics 

Bioindustry Park del Canavese
Via Ribes 5
Colleretto Giacosa (TO)    10010  Italy
Phone: 39-0125-53543 Fax: 39-0125-538897


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Creabilis Therapeutics Appoints Professor Gil Yosipovitch and Professor Praveen Anand to its Scientific Advisory Board 7/29/2013 6:22:39 AM    More...
Creabilis Therapeutics Appoints Dr David Roblin as Chief Medical Officer 8/4/2011 10:53:51 AM    More...
Synexus Delivers Fast Phase II Study Patients for Creabilis Therapeutics 5/16/2011 10:00:40 AM    More...
Creabilis Therapeutics Appoints Dr. Eliot Forster as its New Chief Executive Officer 9/29/2010 6:32:52 AM    More...
Creabilis Appoints George F. Horner III as its Chairman 9/16/2010 12:52:23 PM    More...
Creabilis Therapeutics Appoints Anthony Wilson as New Chief Executive Officer 6/16/2008 11:18:13 AM    More...
Bioindustry Park Announces the Sudden Death of Silvano Fumero 1/9/2008 9:03:08 AM    More...
Nautilus Biotech And Creabilis Therapeutics Achieve Technical Milestone In Collaboration To Improve HMGB1 Box A For The Treatment Of Rage- And HMGB1-Related Pathologies 11/14/2006 10:41:43 AM    More...
Bio3 Research And Creabilis Therapeutics Sign Research Agreements With Cephalon, Inc. (CEPH) 12/8/2005 10:32:04 AM    More...
Bio3 Research And Creabilis Therapeutics Sign Research Agreements With Cephalon, Inc. (CEPH) Research Will Focus On Potential New Treatments For Psoriasis And Restenosis 12/1/2005 12:31:44 PM    More...
12